Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 2mCRC 1RAS Wild Type mCRC 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1Liver Metastases of Colorectal Cancer 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Oxaliplatin 1Leucovorin 1Fluorouracil 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Liver Metastases of Colorectal Cancer × Cetuximab × Clear all
NCT06490913 2024-07-08

Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

Fujian Cancer Hospital

Phase 2 Not yet recruiting
33 enrolled
Gastrointestinal

Liver Metastases of Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡